Questions about this study?
The HopeStage team will email you.
TerminatedNCT06673368
A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder
Medication studyAges 13–17United StatesADHD
Understand this study
Who could participate?
This study is for people with ADHD. Listed age limits: 13 years to 17 years. Other eligibility criteria apply.
- Listed locations
- Maitland, United States · Decatur, United States and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 25, 2025
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 2
- Sponsor
- Neurocentria, Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 13 Years to 17 Years
- Official registry ID
- NCT06673368
- Official title
Show the full official title
A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder
Recruitment & locations
TerminatedMaitland · Decatur · Savannah
2 more locations
- Boston
- Las Vegas
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Neurocentria, Inc.
Does this study involve medication?
Yes. The study involves medication, including NRCT-101SR, NRCT-202XR.
Who can participate?
This study is for people with ADHD. Listed age limits: 13 years to 17 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me